DHR
DANAHER CORP /DE/
NYSE: DHR · Washington, DC · Industrials
$230.50+0.75 (+0.33%)Closed
Market Cap$162.13B
Cash$5.69Bmost recent
Runwayprofitable
P/E (TTM)45.6EPS $5.05
52-Wk Range$161.29 – $240.61
Avg Volume4.3M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$230.50-5.8%
Pipeline
Drug candidates sponsored by DANAHER CORP /DE/ · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for DHR. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.